Back to the drug test guide

Methadone Test Evidence

Has Caused a False Positive

Cyamemazine

Source Lancelin et al., Clin Chem 2005

What It Found

  • Cyamemazine appeared in many patients with unconfirmed methadone screens and produced positivity when added to drug-free urine.

Keep in Mind

  • Co-medications were present in some patients.
  • The study concerns a particular reagent formulation.

Test Studied

  • Roche Integra 800 reformulated KIMS methadone, 300 ng/mL

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 0.05% relative response to Cyamemazine.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS methadone urine application on cobas c 501, Table 4

Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

Levomepromazine

Source Lancelin et al., Clin Chem 2005

What It Found

  • Patients receiving levomepromazine were among those with unconfirmed screens.
  • A spiked concentration of 5 mg/L gave a positive signal.

Keep in Mind

  • Historical formulation.
  • Personal risk at a given prescribed dose is unknown.

Test Studied

  • Roche Integra 800 KIMS methadone

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 4.3% relative response to Levomepromazine.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS methadone urine application on cobas c 501, Table 4

Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

Quetiapine

Source Fischer et al., J Clin Psychiatry 2010

What It Found

  • Ten quetiapine-treated patients had unexpected positive screens.
  • The four urine samples checked by GC-MS contained no methadone.

Keep in Mind

  • Six of the ten patients in the later case series lacked urine GC-MS confirmation.

Source Widschwendter et al., Am J Psychiatry 2007

What It Found

  • In an earlier series, three people on quetiapine alone repeatedly screened positive in urine despite negative plasma methadone by LC-MS/MS.

Keep in Mind

  • The earlier three-person series confirmed plasma rather than the screened urine.

Source Pagaduan, J Anal Toxicol 2026

What It Found

  • Quetiapine was also common in a later audit of unconfirmed screens.

Test Studied

  • Subsequent Roche clinical audit

Source Lasić et al., Acta Clin Croat 2012

Keep in Mind

  • A separate case also involved risperidone, so it cannot isolate quetiapine.

Doxylamine

Source Hausmann et al., J Clin Chem Clin Biochem 1983

What It Found

  • Doxylamine poisoning produced a positive methadone screen although mass spectrometry excluded methadone.

Test Studied

  • Syva EMIT-dau methadone

Source Syed et al., BMJ Case Rep 2009

What It Found

  • Another overdose case reported a similar finding.

Test Studied

  • Separate toxicity report

Both sources Hausmann et al., J Clin Chem Clin Biochem 1983 Syed et al., BMJ Case Rep 2009

Keep in Mind

  • These cases involved intoxication.
  • Ordinary sleep-aid doses were not evaluated.

Alimemazine

Source Lancelin et al., Clin Chem 2005

What It Found

  • Alimemazine cross-reacted in spiked urine.
  • It was also a co-medication in some clinical cases.

Keep in Mind

  • The clinical cases involved other phenothiazines, so they do not isolate alimemazine as the sole cause.

Test Studied

  • Roche Integra 800 KIMS methadone

Amitriptyline

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 75,000 ng/mL for 10-hydroxyamitriptyline (a metabolite of amitriptyline) on the Biosite Triage screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 19

Brompheniramine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 75,000 ng/mL for Brompheniramine on the Biosite Triage screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 24

Chlorpromazine

Source Lancelin et al., Clin Chem 2005

What It Found

  • A spiked concentration of 20 mg/L of chlorpromazine gave a positive methadone result.

Keep in Mind

  • This is an analytical challenge.
  • These data do not establish how frequently treatment produces a false-positive clinical result.

Test Studied

  • Roche Integra 800 reformulated KIMS methadone, 300 ng/mL

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 1.3% relative response to Chlorpromazine.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS methadone urine application on cobas c 501, Table 4

Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

Clemastine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 50,000 ng/mL for Clemastine on the Biosite Triage screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 20

Clomipramine

Source Lancelin et al., Clin Chem 2005

What It Found

  • A spiked concentration of 100 mg/L of clomipramine gave a positive methadone result.

Keep in Mind

  • This is an analytical challenge.
  • These data do not establish how frequently treatment produces a false-positive clinical result.

Test Studied

  • Roche Integra 800 reformulated KIMS methadone, 300 ng/mL

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 0.22% relative response to Clomipramine.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS methadone urine application on cobas c 501, Table 4

Also cited: Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

Loperamide

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 75,000 ng/mL for Loperamide on the Biosite Triage screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 23

Pazopanib

Source Hughey and Colby, Clin Chem 2019

What It Found

  • In laboratory follow-up of a medical-records study, pazopanib gave a presumptive positive at an estimated 198.4 micrograms/mL.

Keep in Mind

  • The experimental result does not establish the frequency of false positives at normal dosing.

Test Studied

  • Abbott MULTIGENT methadone, 300 ng/mL

Pentazocine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 100,000 ng/mL for Pentazocine on the Biosite Triage screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 22

Pheniramine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 25,000 ng/mL for Pheniramine on the Biosite Triage screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 18

Propafenone

Source Hughey and Colby, Clin Chem 2019

What It Found

  • In laboratory follow-up of a medical-records study, propafenone gave a presumptive positive at an estimated 83.2 micrograms/mL.

Keep in Mind

  • The experimental result does not establish the frequency of false positives at normal dosing.

Test Studied

  • Abbott MULTIGENT methadone, 300 ng/mL

Thioridazine

Source Lancelin et al., Clin Chem 2005

What It Found

  • A spiked concentration of 100 mg/L of thioridazine gave a positive methadone result.

Keep in Mind

  • This is an analytical challenge.
  • These data do not establish how frequently treatment produces a false-positive clinical result.

Test Studied

  • Roche Integra 800 reformulated KIMS methadone, 300 ng/mL

Depends on the Brand of Test

Diphenhydramine

Source Rogers et al., Pediatr Emerg Care 2010

What It Found

  • A child with suspected diphenhydramine ingestion screened positive for methadone.
  • GC/MS excluded methadone.
  • Added diphenhydramine, but not two tested metabolites, reacted on the same device.

Keep in Mind

  • Evidence concerns a rapid kit and a suspected ingestion.
  • It does not quantify risk after a usual allergy dose.

Test Studied

  • ACON One Step Multi-Drug Multi-Line Screen

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Tapentadol

Source Collins et al., J Anal Toxicol 2012

What It Found

  • Tapentadol and several metabolites reacted on DRI.
  • In one series, all 97 selected unexpected positives contained tapentadol without confirmed methadone.

Keep in Mind

  • The separate DRI EDDP screen was negative in direct challenges.

Source Gomila Muñiz et al., Emergencias 2020

What It Found

  • A second DRI series found five patients with the same discrepancy.

Source Mullins et al., Clin Toxicol (Phila) 2015

What It Found

  • A separate study of 11 patients taking prescribed doses found no false positives on EMIT II.

Keep in Mind

  • The 11-person EMIT II study cannot exclude rarer reactions.

Test Studied

  • Siemens Syva EMIT II

All 3 sources Collins et al., J Anal Toxicol 2012 Mullins et al., Clin Toxicol (Phila) 2015 Gomila Muñiz et al., Emergencias 2020

Keep in Mind

  • The studies used different reagents and cutoffs.

2 sources Collins et al., J Anal Toxicol 2012 Gomila Muñiz et al., Emergencias 2020

Keep in Mind

  • The positive DRI series did not count all exposed patients.

Test Studied

  • DRI parent-methadone EIA (130 ng/mL in the initial study)

Verapamil

Source Lichtenwalner et al., Clin Chem 1998

What It Found

  • A laboratory traced unexpected methadone screens to verapamil metabolites with the earlier reagent.

Source Tsay and Khosropour, Clin Chem 1998

What It Found

  • The manufacturer later reported that replacing its antibody in June 1997 corrected the interference.

Both sources Lichtenwalner et al., Clin Chem 1998 Tsay and Khosropour, Clin Chem 1998

Keep in Mind

  • The historical result is poor support for blaming verapamil on a modern or unidentified assay.
  • Check the exact reagent with the testing laboratory.

Test Studied

  • Diagnostic Reagents methadone EIA: historical 1995–96 reagent lots versus antibody introduced in June 1997

Vortioxetine

Source Uljon et al., Clin Chim Acta 2019

What It Found

  • Seven patients taking typical vortioxetine doses were positive on MDN2 and negative by GC/MS and on two other immunoassays.
  • A metabolite was implicated.

Test Studied

  • Roche KIMS Methadone II (MDN2) versus two alternative platforms

Both sources Uljon et al., Clin Chim Acta 2019 Pagaduan, J Anal Toxicol 2026

Keep in Mind

  • The hospital findings apply to the Roche method.
  • Presence of this medication cannot exclude concurrent methadone.

Chlorpheniramine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 100,000 ng/mL for Chlorpheniramine on the Biosite Triage screen.
  • At least one other reagent in the same table showed no reaction.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 25

Cyclobenzaprine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 50,000 ng/mL for Cyclobenzaprine on the Biosite Triage screen.
  • At least one other reagent in the same table showed no reaction.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 21

Disopyramide

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 10,000 ng/mL for Disopyramide on the Biosite Triage screen.
  • At least one other reagent in the same table showed no reaction.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 15

Levacetylmethadol

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 1.5% cross-reactivity for Levacetylmethadol on the Microgenics CEDIA screen.
  • At least one other reagent in the same table showed no reaction.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Microgenics CEDIA Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 17

Source Cheever et al., J Anal Toxicol 1999

What It Found

  • Levomethadyl (LAAM) added to urine produced strong cross-reactivity in five methadone assays, ranging from 75.3% to 318.3%.
  • Its metabolite methadol also reacted strongly in several methods.

Keep in Mind

  • The investigators spiked urine; the study did not estimate the frequency after taking levomethadyl.

Test Studied

  • Diagnostix and STC ELISAs, Diagnostic Products RIA, Diagnostic Reagents EIA, and Roche KIMS

Mesoridazine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 20,000 ng/mL for Mesoridazine on the Biosite Triage screen.
  • At least one other reagent in the same table showed no reaction.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 31

Phencyclidine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 75,000 ng/mL for Phencyclidine on the Biosite Triage screen.
  • At least one other reagent in the same table showed no reaction.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 32

Promazine

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists reactivity at 50,000 ng/mL for Promazine on the Biosite Triage screen.
  • At least one other reagent in the same table showed no reaction.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Biosite Triage Methadone (parent drug) screen, Krasowski et al. supplement, K
  • METHADONE, row 27

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 0.19% relative response to Promazine.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS methadone urine application on cobas c 501, Table 4

A Related Drug the Test Picks Up

Methadol

Source Cheever et al., J Anal Toxicol 1999

What It Found

  • Added methadol displayed 37.7–97.8% cross-reactivity in these methadone assays.
  • It can be a metabolite of both methadone and levomethadyl.

Keep in Mind

  • This naming refers to methadol in the test, independently of which substance produced it.

Test Studied

  • Diagnostic Reagents EIA, Roche KIMS, Diagnostix ELISA, and Abbott FPIA

The Test Is Made to Find It

Methadone

2 sources Pagaduan, J Anal Toxicol 2026 Neukamm et al., Drug Test Anal 2017

What It Found

  • A prescribed methadone dose can give an expected positive on a dedicated methadone test.

Source Wolf et al., J Clin Lab Anal 2014

What It Found

  • Laboratories may also measure EDDP separately.

Keep in Mind

  • The parent drug and EDDP are different targets.

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 110% for racemic methadone and 1.8% for EDDP relative response.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS methadone urine application on cobas c 501, Table 4

2 sources Pagaduan, J Anal Toxicol 2026 Wolf et al., J Clin Lab Anal 2014

Keep in Mind

  • Timing, cutoff and formulation of the assay affect detection.

Source Pagaduan, J Anal Toxicol 2026

Test Studied

  • Urine parent-methadone immunoassays

A Problem With the Urine Sample

Creatinine

Source Fucci, Forensic Sci Int 2005

What It Found

  • A case report attributed a false-positive methadone screen to creatinine, a normal constituent of urine.

Keep in Mind

  • The indexed letter has no abstract.
  • The concentration, frequency and applicability to other methadone screens could not be verified.
  • Creatinine is distinct from creatine supplements.

Test Studied

  • EMIT dau urine methadone immunoassay

Suspected, but Not Proven

Labetalol

Source Ayala-Lopez et al., J Anal Toxicol 2022

What It Found

  • Patients with a record of labetalol use had more unconfirmed positive screens in one hospital study.
  • Adding labetalol to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.

Keep in Mind

  • A medication list records prior use.
  • It cannot identify what was in a particular specimen or which substance produced a signal.

Test Studied

  • Alere Integrated E-Z Split Key Cup II urine Methadone (parent drug) screen

Prazosin

Source Ayala-Lopez et al., J Anal Toxicol 2022

What It Found

  • Patients with a record of prazosin use had more unconfirmed positive screens in one hospital study.
  • Adding prazosin to urine did not produce a positive on the same device, even at 1,600 micrograms/mL.

Keep in Mind

  • A medication list records prior use.
  • It cannot identify what was in a particular specimen or which substance produced a signal.

Test Studied

  • Alere Integrated E-Z Split Key Cup II urine Methadone (parent drug) screen

Chlorprothixene

Source Neukamm et al., Drug Test Anal 2017

What It Found

  • The modified assay yielded 0.1% relative response to Chlorprothixene.

Keep in Mind

  • The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
  • Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.

Test Studied

  • Modified Roche KIMS methadone urine application on cobas c 501, Table 4

Tested: No False Positive Found

Acetaminophen

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Dextromethorphan

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels

Levofloxacin

Source Colby et al., Clin Biochem 2019

What It Found

  • Levofloxacin did not react with this dedicated methadone reagent in the modern fluoroquinolone comparison.

Keep in Mind

  • Other assays in the same study were affected, including CEDIA buprenorphine and MULTIGENT opiates.

Test Studied

  • Abbott MULTIGENT methadone

Meprobamate

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.

Keep in Mind

  • This is a single challenge level.
  • It cannot rule out interference at a higher concentration or with a different device.

Test Studied

  • NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels